3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
430
OTHER
50
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
19
Mesothelioma, Malignant
13
Retinoblastoma
8
Unspecified Childhood Solid Tumor, Protocol Specific
6
Malignant Solid Neoplasm
4
Sarcoma
3
Neuroblastoma
3
Wilms Tumor
2
Solitary Fibrous Tumor, Pleural
2
Solid Tumor
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Osteosarcoma
2
Optic Nerve Glioma
2
Neoplasms
2
Mesothelioma
2
Melanoma
2
Medulloblastoma
2
Lymphoma
2
Leukemia
2
Hematopoietic and Lymphatic System Neoplasm
2
Gestational Trophoblastic Disease
2
Central Nervous System Neoplasms
2
Astrocytoma
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Thrombocytopenia
1
Testicular Neoplasms
1
Solid Tumor Spine Metastases
1
Interventions
Nivolumab
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Advanced Solid Tumors
×
Other solid neoplasm
×
Clear all
NCT03461952
2024-02-22
NIMBLe
Canadian Cancer Trials Group
Phase 2
Terminated
4 enrolled
4 charts